Safety of Same Day Discharge After Elective Percutaneous Coronary Intervention
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02214082|
Recruitment Status : Completed
First Posted : August 12, 2014
Last Update Posted : July 21, 2017
Study intends to determine if there is any difference in the occurrence of major adverse cardiology events in patients discharged on the same day as their elective cardiac angioplasty or discharged one day after their angioplasty.
Hypothesize that same day discharge is as safe as a day later discharge.
|Condition or disease||Intervention/treatment||Phase|
|Angioplasty Coronary||Other: Same Day Discharge||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||210 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Feasibility and Safety of Same Day Discharge After Elective Percutaneous Coronary Intervention (PCI) in a Tertiary Care Hospital in Karachi, Pakistan.|
|Study Start Date :||September 2014|
|Actual Primary Completion Date :||October 2015|
|Actual Study Completion Date :||October 2015|
No Intervention: Next day discharge
this group will be discharged as is the standard practice at our facility; i.e. the day after the PCI procedure
Experimental: Same Day Discharge
Patients in this arm will be discharged on the same day as their angioplasty.
Other: Same Day Discharge
This group will be discharged home, on the same day after their elective angioplasty
- Mortality [ Time Frame: Within 30 days post angioplasty ]
- Number of patients who require a 2nd angioplasty [ Time Frame: within 30 days of 1st angioplasty ]
- Number of patients with bleed from the angioplasty site [ Time Frame: within 30 days post angioplasty ]
- number of hospital re-admissions [ Time Frame: within 30 days of initial angioplasty ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02214082
|The Indus Hospital|
|Karachi, Sind, Pakistan|
|Principal Investigator:||Sajid Dhakam||Indus Hospital|